FDA Inspection 703033 — Sato Pharmaceutical Inc.

Sato Pharmaceutical Inc. — FEI 2082295

The FDA completed an inspection of Sato Pharmaceutical Inc. on Dec 21, 2010 in Torrance, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 21, 2010
Fiscal Year
2011
Product Type
Devices
Project Area
Compliance: Devices
Location
Torrance, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.